A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7
A-to-I RNA edited POLA2 attained carcinogenesis in PCa by impeding immune infiltration, fortifying glycolysis and upregulating BTBD7, indicating that edited POLA2 has the potential to become a tool for gene therapy.
Authors
- Hang Huang (ORCID: https://orcid.org/0000-0003-4589-5779)
- Yongyong Lu
- Yeping Li (ORCID: https://orcid.org/0000-0003-0297-5365)
- Tingyu Ye (ORCID: https://orcid.org/0000-0003-2399-8072)
- S. M. Lin
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1007/s12672-025-02449-8
- Citations
- 1
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 0.81